Security
Fulgent Genetics, Inc. Common Stock · FLGT
FLGTNASDAQCommon stockCurrentCIK 1674930Updated Oct 29, 2026
Name history
Fulgent Diagnostics, Inc. · through Jul 15, 2016
FLGT price & chart
Loading TradingView…
NASDAQ:FLGT on TradingView ↗About the company
Fulgent is a technology-based company with a well-established laboratory services business and a therapeutic development business. Fulgent’s laboratory services business includes technical laboratory and testing services and professional interpretation of laboratory results by licensed physicians. Fulgent’s therapeutic development business is focused on developing drug candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The Company aims to transform from a diagnostic business into a fully integrated precision medicine company.
In the news
Fulgent Genetics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses ↗
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 1,214,563,000Source | 1,233,763,000Source | 1,089,223,000Source | 1,199,838,000Source | 1,232,239,000Source | 1,156,369,000Source | 1,205,744,000Source | 1,229,885,000Source | 1,213,525,000Source | 1,219,964,000Source | 1,235,328,000Source | 1,386,053,000Source |
| Property, Plant and Equipment, NetUSD | 111,865,000Source | 106,810,000Source | 113,068,000Source | 110,223,000Source | 93,368,000Source | 116,344,000Source | 107,077,000Source | 86,723,000Source | 112,549,000Source | 105,549,000Source | 83,464,000Source | 81,353,000Source |
| GoodwillUSD | 25,080,000Source | 22,055,000Source | 53,861,000Source | 22,055,000Source | 22,055,000Source | 53,731,000Source | 22,055,000Source | 22,055,000Source | 25,080,000Source | 22,055,000Source | 22,055,000Source | 143,027,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 135,255,000Source | 137,115,000Source | 149,259,000Source | 131,060,000Source | 138,973,000Source | 153,989,000Source | 133,009,000Source | 140,989,000Source | 133,281,000Source | 134,978,000Source | 143,053,000Source | 150,643,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 117,641,000Source | 58,042,000Source | 26,305,000Source | 87,880,000Source | 65,111,000Source | 23,399,000Source | 67,281,000Source | 54,677,000Source | 50,193,000Source | 55,144,000Source | 97,473,000Source | 79,506,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 71,187,000Source | 57,315,000Source | 64,938,000Source | 77,190,000Source | 56,573,000Source | 69,277,000Source | 71,478,000Source | 52,060,000Source | 84,762,000Source | 69,021,000Source | 51,132,000Source | 52,749,000Source |
| Assets, CurrentUSD | 507,374,000Source | 326,539,000Source | 454,770,000Source | 428,727,000Source | 399,104,000Source | 479,042,000Source | 416,784,000Source | 386,509,000Source | 550,490,000Source | 353,571,000Source | 507,845,000Source | 627,873,000Source |
| Operating Lease, Right-of-Use AssetUSD | 4,950,000Source | 5,970,000Source | 7,198,000Source | 4,809,000Source | 9,186,000Source | 7,687,000Source | 5,058,000Source | 9,225,000Source | 4,961,000Source | 5,395,000Source | 10,838,000Source | 14,784,000Source |
| Other Assets, NoncurrentUSD | 23,211,000Source | 39,012,000Source | 23,949,000Source | 23,302,000Source | 32,138,000Source | 24,976,000Source | 32,708,000Source | 32,676,000Source | 22,856,000Source | 33,460,000Source | 34,902,000Source | 44,124,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 93,806,000Source | 98,865,000Source | 93,237,000Source | 88,202,000Source | 103,391,000Source | 112,215,000Source | 82,974,000Source | 103,239,000Source | 106,810,000Source | 90,805,000Source | 102,042,000Source | 116,178,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 3,000Source | 3,000Source | 4,000Source | 3,000Source | 3,000Source | 4,000Source | 3,000Source | 3,000Source | 3,000Source | 3,000Source | 3,000Source | 3,000Source |
| Retained Earnings (Accumulated Deficit)USD | 553,372,000Source | 596,355,000Source | 475,598,000Source | 559,980,000Source | 611,003,000Source | 505,128,000Source | 578,937,000Source | 619,713,000Source | 529,954,000Source | 590,467,000Source | 633,175,000Source | 801,000,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 6,823,000Source | 9,178,000Source | 1,920,000Source | 5,998,000Source | -877,000Source | 4,536,000Source | 4,335,000Source | -1,102,000Source | 7,512,000Source | -368,000Source | 1,205,000Source | -20,903,000Source |
| Stockholders' Equity Attributable to ParentUSD | 1,125,888,000Source | 1,138,445,000Source | 1,001,619,000Source | 1,116,580,000Source | 1,132,549,000Source | 1,049,809,000Source | 1,127,178,000Source | 1,129,943,000Source | 1,111,989,000Source | 1,133,228,000Source | 1,136,101,000Source | 1,266,685,000Source |
| Additional Paid in Capital, Common StockUSD | 565,690,000Source | 532,909,000Source | 524,097,000Source | 550,599,000Source | 522,420,000Source | 540,141,000Source | 543,903,000Source | 511,329,000Source | 574,520,000Source | 543,126,000Source | 501,718,000Source | 486,585,000Source |
| Liabilities and EquityUSD | 1,214,563,000Source | 1,233,763,000Source | 1,089,223,000Source | 1,199,838,000Source | 1,232,239,000Source | 1,156,369,000Source | 1,205,744,000Source | 1,229,885,000Source | 1,213,525,000Source | 1,219,964,000Source | 1,235,328,000Source | 1,386,053,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 72,426,000Source | 73,990,000Source | 71,756,000Source | 71,335,000Source | 75,751,000Source | 90,134,000Source | 65,915,000Source | 75,949,000Source | 84,967,000Source | 72,899,000Source | 73,018,000Source | 88,107,000Source |
| Operating Lease, Liability, CurrentUSD | 1,487,000Source | 1,481,000Source | 1,855,000Source | 1,187,000Source | 2,288,000Source | 1,932,000Source | 1,330,000Source | 2,910,000Source | 1,462,000Source | 1,443,000Source | 3,957,000Source | 6,132,000Source |
| Accounts Payable, CurrentUSD | 18,088,000Source | 19,805,000Source | 15,555,000Source | 18,887,000Source | 19,873,000Source | 21,125,000Source | 18,238,000Source | 19,616,000Source | 18,654,000Source | 18,364,000Source | 15,360,000Source | 23,093,000Source |
| Operating Lease, Liability, NoncurrentUSD | 3,622,000Source | 4,662,000Source | 5,609,000Source | 3,765,000Source | 7,155,000Source | 6,008,000Source | 3,893,000Source | 6,579,000Source | 3,781,000Source | 4,120,000Source | 7,147,000Source | 8,795,000Source |
| Deferred Income Tax Liabilities, NetUSD | 7,040,000Source | 6,734,000Source | 6,892,000Source | 6,124,000Source | 6,948,000Source | 6,982,000Source | 6,237,000Source | 7,405,000Source | 6,936,000Source | 6,370,000Source | 7,962,000Source | — |
| Other Liabilities, NoncurrentUSD | 7,557,000Source | 11,815,000Source | 8,972,000Source | 5,905,000Source | 14,397,000Source | 9,372,000Source | 6,122,000Source | 13,907,000Source | 7,624,000Source | 6,973,000Source | 15,084,000Source | 18,235,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -5,131,000Source | -3,547,000Source | -5,633,000Source | -4,944,000Source | -3,701,000Source | -5,655,000Source | -4,408,000Source | -3,297,000Source | -5,274,000Source | -4,069,000Source | -2,815,000Source | 3,190,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 23,010,000Source | 23,862,000Source | 23,507,000Source | 21,699,000Source | 26,425,000Source | 34,901,000Source | 16,689,000Source | 25,918,000Source | 34,057,000Source | 24,279,000Source | 30,737,000Source | 24,981,000Source |
| Inventory, Net | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -6,826,000Source | -14,694,000Source | -29,719,000Source | -19,256,000Source | -25,274,000Source | -11,899,000Source | -61,631,000Source | -43,820,000Source | -175,239,000Source | 141,923,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 6,000,000Source | 5,919,000Source | 24,123,000Source | 24,928,000Source | 26,143,000Source | 32,662,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 9,890,000Source | 10,550,000Source | 39,582,000Source | 44,481,000Source | 42,922,000Source | 32,640,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -16,431,000Source | 4,524,000Source | 23,251,000Source | 16,303,000Source | -2,388,000Source | -68,638,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -408,000Source | -658,000Source | 550,000Source | 3,066,000Source | -6,896,000Source | -25,339,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | -1,120,000Source | -133,000Source | -1,214,000Source | -3,736,000Source | 11,466,000Source | -8,280,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 7,097,000Source | -4,431,000Source | -101,638,000Source | 21,060,000Source | 27,003,000Source | 253,520,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | 55,567,000Source | 0Source | -3,775,000Source | — | 399,000Source | 172,679,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 10,939,000Source | 27,729,000Source | 111,371,000Source | -58,352,000Source | 38,898,000Source | -261,314,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 5,202,000Source | 4,718,000Source | 22,574,000Source | 40,315,000Source | 22,207,000Source | 18,775,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 4,200,000Source | 1,887,000Source | 3,036,000Source | 2,899,000Source | 2,732,000Source | 1,768,000Source |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 40,078,000Source | 8,679,000Source | 10,884,000Source | 225,000Source | 25,060,000Source | 74,337,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -44,833,000Source | -11,172,000Source | -14,789,000Source | -4,847,000Source | -47,785,000Source | -77,141,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -26,794,000Source | 12,137,000Source | -4,951,000Source | -42,194,000Source | 17,967,000Source | -85,388,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 117,776,000Source | 58,177,000Source | 26,440,000Source | 88,015,000Source | 23,534,000Source | 67,416,000Source | 50,328,000Source | 55,279,000Source | 97,473,000Source | 79,506,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 44,000Source | 61,000Source | 52,000Source | 512,000Source | 960,000Source | — |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | -551,000Source | -1,633,000Source | 96,445,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | 3,000Source | 11,000Source | 105,000Source | -55,000Source | -149,000Source | -453,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 9,717,000Source | 10,920,000Source | 8,624,000Source | 10,039,000Source | 9,890,000Source | 10,550,000Source | 39,582,000Source | 44,481,000Source | 42,922,000Source | 32,640,000Source |
| Amortization of Intangible AssetsUSD | — | — | 2,025,000Source | 1,993,000Source | 2,603,000Source | 1,990,000Source | 2,031,000Source | 1,990,000Source | 8,031,000Source | 7,965,000Source | 7,845,000Source | 6,497,000Source |
| DepreciationUSD | — | — | 3,900,000Source | 3,800,000Source | 5,000,000Source | 3,900,000Source | 3,900,000Source | 3,800,000Source | 15,700,000Source | 16,400,000Source | 17,500,000Source | 25,500,000Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | — | — | — | — | 9,000Source | 2,000Source | 3,000Source | -320,000Source | -305,000Source | -502,000Source |
| General and Administrative ExpenseUSD | — | — | 23,335,000Source | 20,950,000Source | 27,195,000Source | 26,392,000Source | 27,684,000Source | 25,291,000Source | 116,664,000Source | 88,106,000Source | 88,999,000Source | 111,074,000Source |
| GoodwillUSD | — | — | 25,080,000Source | 22,055,000Source | 53,861,000Source | 22,055,000Source | 53,731,000Source | 22,055,000Source | 25,080,000Source | 22,055,000Source | 22,055,000Source | 143,027,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | — | 120,234,000Source | — |
| Income Tax Expense (Benefit)USD | — | — | -683,000Source | -3,838,000Source | 29,000Source | -2,263,000Source | -704,000Source | 176,000Source | -8,394,000Source | -8,136,000Source | 1,154,000Source | 42,102,000Source |
| InterestExpenseNonoperatingUSD | — | — | 28,000Source | 14,000Source | 59,000Source | 17,000Source | 17,000Source | 14,000Source | 75,000Source | -170,000Source | — | — |
| Investment Income, InterestUSD | — | — | 7,874,000Source | 8,090,000Source | 6,404,000Source | 8,091,000Source | 8,651,000Source | 8,018,000Source | 30,919,000Source | 31,304,000Source | — | — |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | — | — | — | — | — | — | — | — | 62,000Source | -994,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -6,608,000Source | -14,648,000Source | -29,530,000Source | -18,957,000Source | -24,826,000Source | -11,530,000Source | -60,513,000Source | -42,708,000Source | -167,825,000Source | 143,403,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -218,000Source | -46,000Source | -189,000Source | -299,000Source | -448,000Source | -369,000Source | -1,118,000Source | -1,112,000Source | -7,414,000Source | -1,480,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -6,608,000Source | -14,648,000Source | -29,530,000Source | -18,957,000Source | -24,826,000Source | -11,530,000Source | -60,513,000Source | -42,708,000Source | -167,825,000Source | — |
| Nonoperating Income (Expense)USD | — | — | 7,841,000Source | -1,453,000Source | 6,383,000Source | -1,806,000Source | 8,644,000Source | 8,072,000Source | 21,071,000Source | 21,962,000Source | — | — |
| Operating ExpensesUSD | — | — | 50,862,000Source | 43,850,000Source | 61,752,000Source | 54,148,000Source | 56,112,000Source | 48,141,000Source | 221,971,000Source | 181,133,000Source | 299,985,000Source | 188,374,000Source |
| Operating Lease, Lease IncomeUSD | — | — | — | — | — | — | — | — | — | — | 164,000Source | 281,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -5,000Source | 544,000Source | 38,000Source | 46,000Source | 10,000Source | 68,000Source | 153,000Source | 561,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 9,000Source | 0Source | 1,000Source | 51,000Source | 3,000Source | 31,000Source |
| Restructuring CostsUSD | — | — | — | — | — | — | — | — | — | — | — | 2,975,000Source |
| Impairment of Intangible Assets (Excluding Goodwill) | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 84,069,000Source | 71,743,000Source | 85,389,000Source | 81,803,000Source | 71,138,000Source | 73,463,000Source | 322,671,000Source | 283,470,000Source | 289,213,000Source | 618,968,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Operating Income (Loss)USD | — | — | -15,350,000Source | -17,079,000Source | -36,073,000Source | -19,713,000Source | -34,622,000Source | -19,795,000Source | -91,096,000Source | -73,918,000Source | -195,529,000Source | 178,527,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -5,000Source | 544,000Source | 38,000Source | 46,000Source | 10,000Source | 68,000Source | 153,000Source | 561,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -7,509,000Source | -18,532,000Source | -29,690,000Source | -21,519,000Source | -25,978,000Source | -11,723,000Source | -70,025,000Source | -51,956,000Source | -174,085,000Source | 184,025,000Source |
| Income Tax Expense (Benefit)USD | — | — | -683,000Source | -3,838,000Source | 29,000Source | -2,263,000Source | -704,000Source | 176,000Source | -8,394,000Source | -8,136,000Source | 1,154,000Source | 42,102,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -218,000Source | -46,000Source | -189,000Source | -299,000Source | -448,000Source | -369,000Source | -1,118,000Source | -1,112,000Source | -7,414,000Source | -1,480,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -6,608,000Source | -14,648,000Source | -29,530,000Source | -18,957,000Source | -24,826,000Source | -11,530,000Source | -60,513,000Source | -42,708,000Source | -167,825,000Source | 143,403,000Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 30,749,000Source | 30,416,000Source | 28,005,000Source | 30,544,000Source | 30,881,000Source | 30,832,000Source | 30,777,000Source | 30,235,000Source | 29,784,000Source | 30,097,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 30,749,000Source | 30,416,000Source | 28,005,000Source | 30,544,000Source | 30,881,000Source | 30,832,000Source | 30,777,000Source | 30,235,000Source | 29,784,000Source | 30,964,000Source |
| Interest Expense (non-operating)USD | — | — | 28,000Source | 14,000Source | 59,000Source | 17,000Source | 17,000Source | 14,000Source | 75,000Source | -170,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 2,025,000Source | 1,993,000Source | 2,603,000Source | 1,990,000Source | 2,031,000Source | 1,990,000Source | 8,031,000Source | 7,965,000Source | 7,845,000Source | 6,497,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -7,260,000Source | -4,400,000Source | -10,312,000Source | 50,382,000Source |
| General and Administrative ExpenseUSD | — | — | 23,335,000Source | 20,950,000Source | 27,195,000Source | 26,392,000Source | 27,684,000Source | 25,291,000Source | 116,664,000Source | 88,106,000Source | 88,999,000Source | 111,074,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | — | 120,234,000Source | — |
| Gross ProfitUSD | — | — | 35,512,000Source | 26,771,000Source | 25,679,000Source | 34,435,000Source | 21,490,000Source | 28,346,000Source | 130,875,000Source | 107,215,000Source | 104,456,000Source | 366,901,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -61,759,000Source | -46,813,000Source | -147,464,000Source | 189,406,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | -0.21Source | -0.48Source | -1.05Source | -0.62Source | -0.8Source | -0.37Source | -1.97Source | -1.41Source | -5.63Source | 4.76Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | -0.21Source | -0.48Source | -1.05Source | -0.62Source | -0.8Source | -0.37Source | -1.97Source | -1.41Source | -5.63Source | 4.63Source |
| Interest and Other IncomeUSD | — | — | — | — | — | — | — | — | — | — | 21,444,000Source | 5,498,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 346,000Source |
| Investment Income, InterestUSD | — | — | 7,874,000Source | 8,090,000Source | 6,404,000Source | 8,091,000Source | 8,651,000Source | 8,018,000Source | 30,919,000Source | 31,304,000Source | — | — |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | — | — | — | — | — | — | — | — | 62,000Source | -994,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -6,608,000Source | -14,648,000Source | -29,530,000Source | -18,957,000Source | -24,826,000Source | -11,530,000Source | -60,513,000Source | -42,708,000Source | -167,825,000Source | — |
| Nonoperating Income (Expense)USD | — | — | 7,841,000Source | -1,453,000Source | 6,383,000Source | -1,806,000Source | 8,644,000Source | 8,072,000Source | 21,071,000Source | 21,962,000Source | — | — |
| Operating ExpensesUSD | — | — | 50,862,000Source | 43,850,000Source | 61,752,000Source | 54,148,000Source | 56,112,000Source | 48,141,000Source | 221,971,000Source | 181,133,000Source | 299,985,000Source | 188,374,000Source |
| Operating Lease, Lease IncomeUSD | — | — | — | — | — | — | — | — | — | — | 164,000Source | 281,000Source |
| Research and Development ExpenseUSD | — | — | 13,860,000Source | 11,783,000Source | 14,554,000Source | 13,480,000Source | 14,176,000Source | 12,395,000Source | 53,905,000Source | 48,816,000Source | 41,440,000Source | 28,910,000Source |
| Restructuring CostsUSD | — | — | — | — | — | — | — | — | — | — | — | 2,975,000Source |
| Selling and Marketing ExpenseUSD | — | — | 11,642,000Source | 9,124,000Source | 15,228,000Source | 12,286,000Source | 12,221,000Source | 8,465,000Source | 43,371,000Source | 36,246,000Source | 41,467,000Source | 38,918,000Source |
| Lease Income | — | — | — | — | — | — | — | —Source | — | — | — | — |
Filing attachments
flgt-ex99_1.htm · 8-K · 2026-07-30
EX-99.1 2 flgt-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Fulgent Reports Second Quarter 2026 Financial Results • Revenue of $85.4 million, growing 20.1% sequentially • GAAP gross profit of $25.7 million, or GAAP gross margin of 30.1%; Non-GAAP gross profit of $26.8 million, or Non-GAAP gross margin of 31.3% • GAAP loss of $29.5 million, or $(1.05) per share; Non-GAAP loss of $16.2 million, or $(0.58) per share • Executed on stock repurchase program; purchased approximately 1.5 million sh…
Read attachment ↗flgt-ex99_2.htm · 8-K · 2026-07-30
EX-99.2 3 flgt-ex99_2.htm EX-99.2 Founded in 2011 | Located in El Monte, CA | NASDAQ:FLGT Investor Presentation July 30, 2026 Disclaimer Forward-Looking Statements and Market Data This presentation contains forward-looking statements, which are statements other than those of historical facts and which represent the estimates and expectations of Fulgent Genetics, Inc. (the “Company” or “Fulgent”) about future events based on current views and assumptions. Examples of forward-looking statemen…
Read attachment ↗flgt-ex99_1.htm · 8-K · 2026-06-02
EX-99.1 2 flgt-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Fulgent Presents Updated FID-007 Data at ASCO 2026 EL MONTE, Calif. - June 1, 2026 - Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with established laboratory services and therapeutic development businesses, today announced it presented updated data in the Head and Neck Cancer Track during the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting Rapid Oral Abstract Session, …
Read attachment ↗flgt-ex99_1.htm · 8-K · 2026-05-21
EX-99.1 2 flgt-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting EL MONTE, Calif. - May 21, 2026 - Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that its full abstract has been released on the ASCO 20…
Read attachment ↗flgt-ex99_1.htm · 8-K · 2026-05-01
EX-99.1 2 flgt-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Fulgent Reports First Quarter 2026 Financial Results • Reiterates revenue guidance for fiscal year 2026 • Executed on stock repurchase program; purchased approximately 2.6 million shares in the first quarter of 2026 using $40.1 million in cash • Revenue of $71.1 million • GAAP gross profit of $21.5 million, or GAAP gross margin of 30.2%; Non-GAAP gross profit of $23.0 million, or Non-GAAP gross margin of 32.3% • GAAP loss of $24.8…
Read attachment ↗flgt-ex99_2.htm · 8-K · 2026-05-01
EX-99.2 3 flgt-ex99_2.htm EX-99.2 Founded in 2011 | Located in El Monte, CA | NASDAQ:FLGT Investor Presentation May 1, 2026 Disclaimer Forward-Looking Statements and Market Data This presentation contains forward-looking statements, which are statements other than those of historical facts and which represent the estimates and expectations of Fulgent Genetics, Inc. (the “Company” or “Fulgent”) about future events based on current views and assumptions. Examples of forward-looking statements…
Read attachment ↗